Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Interest Income - Net (2021 - 2025)

Historic Interest Income - Net for BioRestorative Therapies (BRTX) over the last 5 years, with Q3 2025 value amounting to $57740.0.

  • BioRestorative Therapies' Interest Income - Net fell 6358.18% to $57740.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $350609.0, marking a year-over-year decrease of 5985.3%. This contributed to the annual value of $616077.0 for FY2024, which is 1154.89% up from last year.
  • As of Q3 2025, BioRestorative Therapies' Interest Income - Net stood at $57740.0, which was down 6358.18% from $73915.0 recorded in Q2 2025.
  • BioRestorative Therapies' 5-year Interest Income - Net high stood at $376223.0 for Q4 2023, and its period low was -$1.8 million during Q4 2021.
  • Moreover, its 5-year median value for Interest Income - Net was $67791.0 (2023), whereas its average is -$31761.9.
  • In the last 5 years, BioRestorative Therapies' Interest Income - Net surged by 312938.2% in 2023 and then crashed by 6837.3% in 2024.
  • Quarter analysis of 5 years shows BioRestorative Therapies' Interest Income - Net stood at -$1.8 million in 2021, then surged by 100.64% to $11650.0 in 2022, then skyrocketed by 3129.38% to $376223.0 in 2023, then crashed by 68.37% to $118988.0 in 2024, then plummeted by 51.47% to $57740.0 in 2025.
  • Its Interest Income - Net stands at $57740.0 for Q3 2025, versus $73915.0 for Q2 2025 and $99966.0 for Q1 2025.